The short version of peptide purity fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-21 and is reviewed periodically as new material appears.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Peptides are sensitive to temperature, light, oxygen, and repeated freeze-thaw cycles. Semaglutide in dry form is generally held at refrigerated temperatures, while reconstituted solutions require a defined short-term storage window. Vials should be kept in secondary packaging to limit photodegradation, and exposure to alkaline conditions is avoided because it accelerates chemical degradation. Adsorption to glass and some plastics can reduce the measured concentration of dilute solutions, so low-binding polypropylene containers are preferred for analytical work. Each transfer step introduces a small risk of contamination, and closed handling practices reduce that risk.
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
Material described as research-grade is not necessarily manufactured to pharmaceutical standards, and purity figures depend on the method used to obtain them. A certificate of analysis states the measured purity, the analytical technique, and the batch identifier, but the underlying data are not always included. Independent testing by a second laboratory is a common way to confirm identity and purity. Uncertainties remain about how storage history affects long-term stability, and about how well results from one laboratory transfer to another. Documentation of handling conditions supports comparison between batches.
| Property | Value | Notes |
|---|---|---|
| Molecular class | 31-amino-acid peptide | Modified glucagon-like peptide-1 analogue |
| Molecular mass | approximately 4114 Da | Calculated for the free peptide backbone |
| Appearance | white to off-white powder | Typical of purified lyophilised peptide batches |
| Solubility class | freely soluble in water | Aqueous solubility improves at slightly alkaline pH |
| Typical storage | -20 degrees Celsius, dry, dark | Protect from repeated freeze-thaw cycles |
Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 or 280 nanometres is widely used to assess purity and to resolve related impurities. Liquid chromatography coupled to mass spectrometry confirms identity through the protonated molecular ion and fragment ions formed in tandem experiments. Capillary electrophoresis and peptide mapping after enzymatic digestion supply complementary information on charge variants and modification sites. Circular dichroism and nuclear magnetic resonance can report on secondary structure in solution. Absolute quantification usually depends on an external standard, and reported purity depends on the detection wavelength and integration parameters chosen.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
It is indeed simultaneously realized that the TLC methods used thus far in almost all published studies on INMT and DMT biosynthesis are incapable to resolve DMT from those tetrahydro-β-carbolines. These findings are a blow for all previous claims of evidence of INMT activity and DMT biosynthesis in avian and mammalian brain, including in vivo, as they all relied upon use of the problematic TLC methods: their validity is doubted in replication studies that make use of improved TLC methods, and fail to evidence DMT-producing INMT activity in rat and human brain tissues. Published in 1978, the last study attempting to evidence in vivo INMT activity and DMT production in brain (rat) with TLC methods finds biotransformation of radiolabeled tryptamine into DMT to be real but "insignificant". Capability of the method used in this latter study to resolve DMT from tetrahydro-β-carbolines is questioned later. To localize INMT, a qualitative leap is accomplished with use of modern techniques of molecular biology, and of immunohistochemistry. In humans, a gene encoding INMT is determined to be located on chromosome 7. Northern blot analyses reveal INMT messenger RNA (mRNA) to be highly expressed in rabbit lung, and in human thyroid, adrenal gland, and lung. Intermediate levels of expression are found in human heart, skeletal muscle, trachea, stomach, small intestine, pancreas, testis, prostate, placenta, lymph node, and spinal cord. Low to very low levels of expression are noted in rabbit brain, and human thymus, liver, spleen, kidney, colon, ovary, and bone marrow.
Originally a Russian production, all in Russian with subtitles, produced by Maciej Drygas 15 October High Anxiety, about lifts and the required extensive technology of tall office buildings; Canary Wharf Tower (One Canada Square) had 50 floors with 36 lifts, which could travel up to 13.5 mph; Jim Fortune of Lerch Bates; novelist Philip Kerr; Otis Elevators alarm response centre of Farmington, Connecticut, which dealt with trapped passengers - it took about 20 minutes to rescue people; the Otis Test Tower, at Bristol in Connecticut, which had 29 floors and 11 lifts; architect Ken Yeang of Malaysia, known for his tall buildings; Gary Faltin of Otis; in the distant past, due to ropes, only goods were carried by lifts; in 1853 Elisha Otis invented a safety system for lifts, via a governor cable; only once have steel lift cables snapped, on 28 July 1945, in the 1945 Empire State Building B-25 crash after being lost in fog, severing the lift governor cable; if the cable snapped, due to the lift being balanced only after about nine people were in a lift, the lift would go upwards; on 12 August 1995, in the Empire State Building, a lift did go upwards, to be trapped at the 80th floor; the Woolworth Building, with 57 floors and 26 lifts, which could travel up to 10 mph - it was the world's tallest building from 1911 to 1930; engineer William Sheeran of Otis; medical doctor Rollin Stott, of the Linear Motion Laboratory of the Defence Research Agency (DERA) Centre for Human Sciences in north-east Hampshire; the feelings in the stomach, often sensed in a lift, comes from a pulse of adrenaline; Convent of Sacred Heart, with six floors; Nicole Fenchel was phobic of lifts; Doreen Powell of White Plains Hospital; the express lift, for the observation platform, in Tower 2 of the former World Trade Center had a journey time of 58 seconds; the former WTC had the world's second and third tallest office buildings; Tower 1 had 110 floors, being 417 metres high, with 96 lifts that could travel up to 15 mph; 70,000 people worked in the former WTC; people should not have to wait for a lift for no more than 30 seconds; Roger Howkins of Arup in London; 200 Vesey Street, known as Three World Financial Center, with 51 floors and 39 lifts, that could travel up to 14 mph; the former WTC was the first building to introduce the sky lobby design, with interspersed lifts; Robert DiChiara, assistant director of the former WTC; engineer Bruce Powell of Otis; Argentine architect, César Pelli, who designed One Canada Square of Canary Wharf; control systems of lifts anticipated demand; but there was a dark and menacing side to travel by lifts - Detectives Kevin Dineen and Lisa McClean of the NYPD Elevator Squad, at Carver Houses in the East Village, Manhattan, and how criminals could isolate victims; local youths and children would travel on top of the elevators for momentary thrills; the New York Marriott Marquis hotel, with 49 floors and 12 elevators, which could travel up to 15 mph; the Petronas Towers in Malaysia, with 88 floors, and 76 lifts, that could travel up to 16 mph, to be completed by 1997; lift ropes could go up to 600 metres, at the extreme most; new lifts would be powered by tubular linear motors or AC induction motors; 600 lifts with these new motors were operating in Japan; Yebisu Garden Place in Ebisu, Shibuya in Tokyo, where linear motors powered the lift counterweight; the Nishi-Shinjuku district in Shinjuku, Tokyo; many tall buildings were being built in Japan; Riverside Sumida Center, of Tokyo, built in 1994; the Yokohama Landmark Tower, with 70 floors, in Japan, built in 1993; Mitsubishi Electric had the world's fastest lifts, up to 28 mph; Junichi Sato of Mitsubishi, who said that he thought that Japanese people valued well-made products, and only trusted manufacturers too, whereas he thought that Americans and Europeans merely wanted functional products, whether good or not; the proposed enormous 800 metre Millennium Tower (Tokyo) for Tokyo Bay, with 150 floors, which was never built, but the Gherkin (30 St Mary Axe) was built instead; architect Andrew Miller of Foster Asia; there were twenty buildings over 60 floors being built; the Chinese economy was growing by 15% per year, and was Mitsubishi's biggest customer; the Century Tower (Tokyo), built in 1991, with 21 floors, with 14 lifts, that could travel up to 11 mph; lift technology had allowed Western business to prosper, but now it was superfluous for Western business. Narrated by Paul McGann, produced by Elizabeth Allen, directed by Gary Johnstone, made by Diverse Productions 22 October DNA in the Dock, an Equinox Special that was an update on the Incredible Evidence episode on 28 December 1994; The murder of 15-year-old Claire Hood, last seen on 19 January 1995, where 2,100 men had their DNA tested; her body was found in Cath Cobb Woods the next day; Sir Alec Jeffreys claimed that he could tell anyone apart; Timothy Wilson Spencer was the first person to be executed, with DNA evidence, on 27 April 1994, having committed murder in 1988; DCI Stuart Lewis, who worked on the Claire Hood investigation, who believed that her killer lived nearby - her killer lived 100 yards away; the United Kingdom National DNA Database began earlier in 1995, and in six months, 60,000 DNA specimens were recorded, and the database was intended to have 5 million specimens; an investigation of Orchid Cellmark, part of ICI, found that errors in correlation of specimens were made; California police gave test specimens to Cellmark, and errors were found, which Cellmark attributed to cross-contamination; Donald Findlay and a Scottish rape investigation in Largs, North Ayrshire, in 1987; former policeman Brian Kelly, and his wrongful conviction, for six years, serving four of them, for rape on 30 November 1989, through DNA evidence alone - DNA testing would later change in 1990, where crime scene DNA specimens were kept apart; Kary Mullis, who invented the PCR test in 1983, receiving the 1993 Nobel Prize in Chemistry, and knew about errors in DNA genetic testing; David Werrett of the Forensic Science Service, who set up the UK national DNA database in Birmingham, which deployed the PCR method - the more reliable Second Generation Multiplex Plus would be later introduced in 1999; Don Dovaston, later the deputy chief of Derbyshire Constabulary, which was the first police force to identify suspects through the UK DNA database; the Metropolitan Police had its own DNA database; Larry Mueller, population geneticist at the UCI School of Biological Sciences. Produced by David Poyser, directed by Hilary Lawson, made by TVF 5 November Kaboom!, the explosives engineer Sidney Alford; Controlled Demolition, Inc., founded by Jack Loizeaux; Rev Ron Lancaster, originally from Huddersfield, who founded Kimbolton Fireworks in 1964, when a chemistry teacher at Kimbolton School; in 1847 Ascanio Sobrero of Italy discovered nitroglycerin - nitroglycerin is the main component of dynamite; a detonation occurs at supersonic speed; Semtex was developed in Czechoslovakia in the 1960s; Ballistite, made from nitroglycerin and discovered in 1887, is the propellant for guns. Joint-production with NOVA and WGBH. Shown on Nova on 14 January 1997 12 November Avalanche, avalanches kill around two hundred people a year, with 120 of those in the Alps; Swiss physicist Othmar Buser of the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL), who developed a database of avalanches; Bruce Tremper; Doug Fesler; powder snow avalanches can reach 150 mph; Laurent Buisson. Narrated by Heather Couper, made by Pioneer Productions with Discovery Networks 19 November God only Knows, about how some physicists see theology being explained through physics, such as Frank J. Tipler of Tulane University and his book The Physics of Immortality; George Johnson (writer) and book titles; Lewis Wolpert and how there was no evidence for God in the external world; David Finley of the National Radio Astronomy Observatory; religious writer Karen Armstrong, author of A History of God; Brazilian physicist Marcelo Gleiser; physicist Leon M. Lederman; Russell Stannard and physics before the big bang; the KTeV experiment at Fermilab, which looked at kaons, and Vivian O'Dell; Rev John Polkinghorne, former professor of Mathematical Physics at the University of Cambridge. Narrated by Bill Paterson, produced by Nicolas Kent, directed by Peter Webber 26 November Gloria's Toxic Death, about the death of Gloria Ramirez in California on 19 February 1994; a nurse, who took a blood sample from her, passed out from inhaling an unknown vapour coming from the blood sample; few episodes of Doctor Who had such a bizarre and unbelievable storyline; blood tests from the nurses revealed a lowering of the enzyme cholinesterase, which in other cases is linked to organophosphate poisoning; the Lawrence Livermore National Laboratory proposed a connection to dimethyl sulfoxide (DMSO) that had combined with oxygen given in the hospital to make dimethyl sulfate; the conditions of the hospital were repeated in a test, and the results underwent gas chromatography–mass spectrometry by Yolanda de Miguel at Department of Chemistry, Imperial College London. Narrated by Neil Pearson, directed by Tim Shawcross, produced by Geoff Deehan, made by Union Pictures with Discovery Communications 3 December On Jupiter, about the large gravitational effect that Jupiter has on the solar system; if the mass of Jupiter was thirty times bigger, the heat in its centre could sustain nuclear reactions, and it could become a star, maybe a brown dwarf; Gene Shoemaker of the Lowell Observatory and Palomar Observatory; Galileo Galilei discovered Jupiter's moons, Io, Europa, Ganymede (the largest moon in the solar system), and Callisto, on 7 January 1610; Heidi Hammel of MIT; Galileo (spacecraft), built at JPL and Ames in the 1980s, being planned to have launched in 1982, arrived at Jupiter on 7 December 1995; Torrence Johnson of JPL; Jim Scotti of the Spacewatch project at Kitt Peak National Observatory; Brian G. Marsden of the Central Bureau for Astronomical Telegrams; Vicki Meadows of the Anglo-Australian Telescope; Imke de Pater of the W. M. Keck Observatory on Mauna Kea; David Morrison (astrophysicist) of NASA Ames. Narrated by John Hurt, directed by Richard Smith, made by Pioneer Productions and the Discovery Channel 10 December Designing Dream Machines, about product innovation and product design of food processors and a reinvented motorbike by the Seymour-Powell design agency and its designer Nick Talbot, with the management team of Tefal UK and its managing director and a design by 43-year-old Dick Powell, and a possible new design of the ubiquitous 125CC BSA Bantam motorbike for MZ Motorrad- und Zweiradwerk of Germany by 42-year-old Richard Seymour; the 59 Club; Leigh Martin of the defunct Comet (closed in December 2012). Narrated by Marilyn Milgrom, directed by Richard Burke, produced by Richard Reisz. TV6 went on to make the six-part series Better by Design 17 December It Runs on Water, about the field commonly known as fringe science, where physicist Frank Close was sceptical if not broadly dismissive, stating that 300 years of science could not be overruled, but a professor of Aeronautics Paul Csysz of Saint Louis University mentioned that he thought some people in science were often unquestioning of their lifelong-held beliefs, and nervous of anyone trying to do so; an invention in Moscow was looked at by American physicist Harold E. Puthoff; Stanley Meyer's water fuel cell; NASA's propulsion research at Lewis Research Center in Cleveland, Ohio; it ends with Sir Arthur C. Clarke and Requiem (Mozart). Directed by Lawrence Simanowitz, produced and narrated by William Woollard, made by InCA Productions with Discovery Communications 20 December Do Vampire Bats have Friends?, an Equinox Special about whether animals have consciousness; zoologist Prof John Krebs, Baron Krebs, and whether animals had human-like sentience; biologist Gerald Wilkinson of the University of Maryland, and research, over five years, into relationships of vampire bats with other types of animals, and found food sharing between hungry vampire bats; zoologist Miriam Rothschild; psychologist Cecilia Heyes of UCL and self-perception of chimpanzees; zoologist Bernd Heinrich of the University of Vermont, and puzzle-solving of raven birds; zoologist Benjamin Beck of The National Zoo, and the apparent deployment of tools by animals; Ian Farquhar, and foxhunting, and whether foxes realise their predicament, and the Duke of Beaufort's Hunt in Gloucestershire; biologist Sir Patrick Bateson of the University of Cambridge, sensation of pain in animals, and the Animals (Scientific Procedures) Act 1986, which defined protected animals, that did not cover the octopus, but due to research by the Universities Federation for Animal Welfare (UFAW); Prof Peter Boyle and Martin Wells, and a 1993 amendment added the octopus; Prof Daniel Dennett of Tufts University, and how snakes think; psychologist Irene Pepper berg, of the University of Arizona, and an African Grey parrot called Alex, who has been talking for 18 years; the horse Clever Hans; Robert Seyfarth (scientist) and Dorothy Cheney (scientist), and their work on baboon warning calls and grunts, in Kenya. Narrated by Andrew Sachs, directed by Christopher Sykes, made by Christopher Sykes Productions
In 2005, the JECFA (Joint FAO/WHO Expert Committee On Food Additives) risk-assessment evaluation of ethyl carbamate concluded that the margin of exposure to ethyl carbamate from daily food and alcoholic beverages combined is of concern, and mitigation measures to reduce ethyl carbamate in some alcoholic beverages should continue. Ethyl carbamate exposure through alcoholic beverages has been discussed by multiple health authorities, while the cumulative daily exposure in the typical diet is also an issue of rising concern that merits closer observation. The Korean study concluded that "it would be desirable to closely monitor ethyl carbamate levels in Korean foods and find ways to reduce the daily intake." The following US regulators have mentioned urethane:
Sources: en.wikipedia.org
The common name birch comes from Old English birce, bierce, from Proto-Germanic *berk-jōn (cf. German Birke, West Frisian bjirk), an adjectival formation from *berkōn (cf. Dutch berk, Low German Bark, Danish birk, Norwegian bjørk), itself from the Proto-Indo-European root *bʰerHǵ- ~ bʰrHǵ-, which also gave Lithuanian béržas, Latvian Bērzs, Russian берёза (berëza), Ukrainian береза (beréza), Albanian bredh 'fir', Ossetian bærz(æ), Sanskrit bhurja, Polish brzoza, Czech bříza, Slovak breza. This root is presumably derived from *bʰreh₁ǵ- 'to shine, whiten', in reference to the birch's white bark. The Proto-Germanic rune berkanan is named after the birch. The generic name Betula is from Latin, which is a diminutive borrowed from Gaulish betua (cf. Old Irish bethe, Welsh bedw).
There are some common misconceptions about the outer and inner chloroplast membranes. The fact that chloroplasts are surrounded by a double membrane is often cited as evidence that they are the descendants of endosymbiotic cyanobacteria. This is often interpreted as meaning the outer chloroplast membrane is the product of the host's cell membrane infolding to form a vesicle to surround the ancestral cyanobacterium—which is not true—both chloroplast membranes are homologous to the cyanobacterium's original double membranes. The chloroplast double membrane is also often compared to the mitochondrial double membrane. This is not a valid comparison—the inner mitochondria membrane is used to run proton pumps and carry out oxidative phosphorylation across to generate ATP energy. The only chloroplast structure that can be considered analogous to it is the internal thylakoid system. Even so, in terms of "in-out", the direction of chloroplast H+ ion flow is in the opposite direction compared to oxidative phosphorylation in mitochondria. In addition, in terms of function, the inner chloroplast membrane, which regulates metabolite passage and synthesizes some materials, has no counterpart in the mitochondrion.
=== Basicity === Urea is a weak base, with a pKb of 13.9. When combined with strong acids, it undergoes protonation at oxygen to form uronium salts. It is a Lewis base, forming metal complexes of the type [M(urea)6]n+.
Decrease in testosterone Decrease in serum DHT and 5-alpha reductase Decrease 3AAG, a peripheral marker of DHT metabolism Increase in SHBG Decrease in androgen receptors, 5-alpha reductase type I and II activity, and aromatase in the scalp This decrease in androgens and androgen receptors, and the increase in SHBG, are opposite to the increase in androgenic alopecia with aging. This is not intuitive, as testosterone and its peripheral metabolite, DHT, accelerate hair loss, and SHBG is thought to be protective. The ratio of T/SHBG, DHT/SHBG decreases by as much as 80% by age 80, in numeric parallel to hair loss, and approximates the pharmacology of antiandrogens such as finasteride. Free testosterone decreases in men by age 80 to levels double that of a woman at age 20. About 30% of the normal male testosterone level, the approximate level in females, is not enough to induce alopecia; 60%, closer to the amount found in elderly men, is sufficient. The testicular secretion of testosterone perhaps "sets the stage" for androgenic alopecia as a multifactorial diathesis stress model, related to hormonal predisposition, environment, and age. Supplementing eunuchs with testosterone during their second decade, for example, causes slow progression of androgenic alopecia over many years, while testosterone late in life causes rapid hair loss within a month. An example of premature age effect is Werner's syndrome, a condition of accelerated aging from low-fidelity copying of mRNA. Affected children display premature androgenic alopecia.
Sources: en.wikipedia.org
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.
No. It shares high sequence identity but carries non-natural modifications that alter its stability and clearance. The naturally occurring hormone is broken down within minutes, while the synthetic analogue circulates far longer.
Attachment to serum albumin reduces renal filtration of the peptide and shields it from enzymatic breakdown. The consequence is a much longer interval between administrations than unmodified peptides allow. The precise contribution of binding affinity to overall duration is still being quantified.
Different techniques detect different classes of impurities, so a single number does not describe a sample completely. Reversed-phase chromatography resolves related peptides well but can miss inorganic salts, while mass spectrometry confirms mass without quantifying everything present. Comparing results requires knowing which method was used and how it was validated.